Hematological adaptations and detection of recombinant human erythropoietin combined with chronic hypoxia,Drug Testing and Analysis

当前位置： X-MOL 学术 › Drug Test. Anal. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Hematological adaptations and detection of recombinant human erythropoietin combined with chronic hypoxia
Drug Testing and Analysis ( IF 2.6 ) Pub Date : 2020-09-21 , DOI: 10.1002/dta.2931
Jacob Bejder ₁ , Andreas Breenfeldt Andersen ₁ , Thomas Christian Bonne ₁ , Jesper Linkis ₁ , Niels Vidiendal Olsen ₂ , Jesús Rodríguez Huertas ₃ , Nikolai Baastrup Nordsborg ₁

Affiliation

This study evaluated whether recombinant human erythropoietin (rhEpo) treatment combined with chronic hypoxia provided an additive erythropoietic response and whether the athlete biological passport (ABP) sensitivity improved with hypoxia.

中文翻译：